Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT06460402 Enrolling by invitation - Post Operative Pain Clinical Trials

Ice Therapy and Warm Baths for Hemorrhoidectomy Wound Care

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

This study aims to compare the effectiveness of cryotherapy and warm water sitz bath in post-hemorrhoidectomy wound care. It is a prospective, randomized controlled trial that will assess the impact of these two methods on postoperative pain, analgesic use, wound separation, and swelling.

NCT ID: NCT06460025 Active, not recruiting - Clinical trials for Microbial Colonization

Compare Wound Sampling Methods Efficacy in Microbiology Culture

Start date: October 1, 2022
Phase:
Study type: Observational

Slough was a visible indicator of biofilm, which was the most available specimen from acute and chronic wounds. However, studies believed that slough were poorly accurate, and that the Levine swab was more recommended for sampling bacterial culture. This study aimed to compare slough with swab sample and analyze the consistency.

NCT ID: NCT06459362 Not yet recruiting - Acute Kidney Injury Clinical Trials

Serum Cystatin C for Early Detection of Acute Kidney Injury After Primary Percutaneous Coronary Intervention

Start date: July 1, 2024
Phase:
Study type: Observational

This study aims to evaluate whether the serum levels of Cystatin C (CysC) can be used as early biomarkers for the identification of patients who are prone to AKI after cardiac interventional surgeries as primary percutaneous coronary intervention (PCI)

NCT ID: NCT06455137 Recruiting - Clinical trials for Spinal Cord Injuries

Epidural Electrical Stimulation for Spinal Cord Injury Patients and Corticospinal Motor Circuit Improvement

Start date: April 30, 2024
Phase: N/A
Study type: Interventional

The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.

NCT ID: NCT06452264 Recruiting - Clinical trials for Spinal Cord Injuries

Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study

SCI-IQ
Start date: June 19, 2024
Phase: N/A
Study type: Interventional

This study seeks to conduct a pilot study to test whether a cognitive training program can improve processing speed abilities in individuals with acute traumatic spinal cord injury.

NCT ID: NCT06451133 Not yet recruiting - Clinical trials for Spinal Cord Injuries

Hemodynamic Management Following Acute Traumatic Spinal Cord Injury

Start date: June 15, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of various hemodynamic management strategies on functional neurologic outcomes and non-neurologic adverse events in the first 5 days following acute spinal cord injury (SCI). The hemodynamic management strategies assessed include targeting a mean arterial blood pressure (MAP) goal of 85-90 mmHg, targeting a spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg, or targeting normal hemodynamics, which is a MAP goal of ≥65 mmHg.

NCT ID: NCT06449183 Recruiting - Clinical trials for Mild Traumatic Brain Injury

VIDAS® TBI Performance in Subjects With Mild Traumatic Brain Injury (mTBI)

Start date: May 16, 2024
Phase: N/A
Study type: Interventional

Decision Rules for an initial CT-scan in patients arriving to Emergency Department (ED) and presenting a mild traumatic brain injury could be optimized by the use of an objective parameter easily and rapidly measured. This may be the place for serum biomarkers providing a quick and accurate assessment. BioMérieux has now developed an automated assay for the measurement of serum Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase (UCH-L1), the VIDAS® TBI assay to fill out this unmet needs. The goal of the herein study is to generate real-world data and evidences to support the VIDAS® TBI performances.

NCT ID: NCT06446609 Recruiting - Pruritus Clinical Trials

Drug-induced Liver Injury: Itching Study

Start date: June 14, 2024
Phase:
Study type: Observational

Idiosyncratic drug-induced liver injury (DILI) is an unpredictable adverse hepatic reaction to a medication used in its therapeutic dose. DILI is the second most common cause of itching in adult Hepatology after biliary obstruction. In particular cholestatic or mixed pattern types of DILI (in which bile flow from the liver is impaired) are associated with long-lasting effects as well as reduced quality of life. There is therefore an urgent need to determine the incidence and natural history of itching in DILI and establish a network of centres that will form a basis for a clinical trial to investigate a novel intervention to treat these.

NCT ID: NCT06444672 Completed - Clinical trials for Spinal Cord Injury L1- L5

Effects of a Home-Based Rehabilitation on Anthropometric Measures, Sensory-Motor Functions and Independence After Spinal Cord Injury

HBRSCI
Start date: September 25, 2021
Phase: N/A
Study type: Interventional

Background: The scarcity of resources for spinal cord injury (SCI) rehabilitation constitutes a significant obstacle, particularly in war-torn regions experiencing a rise in such injuries. Implementing a home-based rehabilitative program (HBRP) tailored to patients' environmental, social, and financial contexts is crucial in mitigating this challenge. The authors investigated the effects of a 24-month HBRP on anthropometric measurements, muscular strength, sensory and motor function, and independence in participants transitioning from bed to walking following SCI. Methods: Serial case study in a quasi-experimental design, the conducting was at the participants' homes. The participants were four patients with SCI (experimental group) and another two patients with SCI (control group). The interventions were a 24-month HBRP comprising strength, flexibility, and balance training, the outcome measures involved anthropometric measurements, muscle strength using a digital handheld dynamometer, muscle thickness, and cross-sectional area measured using magnetic resonance imaging, measured five walking tests, and the American Spinal Injury Association scale (ASIA) score for assess the sensory and motor score, and the Spinal Cord Independence Measure (SCIM).

NCT ID: NCT06443281 Recruiting - Clinical trials for Spinal Cord Injuries

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

Start date: April 17, 2024
Phase:
Study type: Observational

The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.